REFERENCES
1. Chilakamarthi U, Giribabu L. Photodynamic therapy: past, present and future. Chem Rec 2017;17:775-802.
2. Cheng YJ, Hu JJ, Qin SY, Zhang AQ, Zhang XZ. Recent advances in functional mesoporous silica-based nanoplatforms for combinational photo-chemotherapy of cancer. Biomaterials 2020;232:119738.
3. Fan W, Huang P, Chen X. Overcoming the Achilles’ heel of photodynamic therapy. Chem Soc Rev 2016;45:6488-519.
4. Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 2019;69:363-85.
5. Chen J, Fan T, Xie Z, et al. Advances in nanomaterials for photodynamic therapy applications: status and challenges. Biomaterials 2020;237:119827.
6. Sun W, Zhou Z, Pratx G, Chen X, Chen H. Nanoscintillator-mediated X-ray induced photodynamic therapy for deep-seated tumors: from concept to biomedical applications. Theranostics 2020;10:1296-318.
7. Liu Z, Cao T, Xue Y, et al. Self-amplified photodynamic therapy through the O2 -mediated internalization of photosensitizers from a Ppa-bearing block copolymer. Angew Chem Int Ed 2020;59:3711-7.
8. Tian J, Zhang W. Synthesis, self-assembly and applications of functional polymers based on porphyrins. Prog Polym Sci 2019;95:65-117.
9. Yanovsky RL, Bartenstein DW, Rogers GS, Isakoff SJ, Chen ST. Photodynamic therapy for solid tumors: a review of the literature. Photodermatol Photoimmunol Photomed 2019;35:295-303.
10. Wang K, Yu B, Pathak JL. An update in clinical utilization of photodynamic therapy for lung cancer. J Cancer 2021;12:1154-60.
11. Zhang Q, Wu L, Liu S, et al. Targeted nanobody complex enhanced photodynamic therapy for lung cancer by overcoming tumor microenvironment. Cancer Cell Int 2020;20:570.
13. Wu W, Shi L, Duan Y, et al. Nanobody modified high-performance AIE photosensitizer nanoparticles for precise photodynamic oral cancer therapy of patient-derived tumor xenograft. Biomaterials 2021;274:120870.
14. Lu K, He C, Lin W. Nanoscale metal-organic framework for highly effective photodynamic therapy of resistant head and neck cancer. J Am Chem Soc 2014;136:16712-5.
15. Rettig EM, D’Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin N Am 2015;24:379-96.
16. Quirk BJ, Brandal G, Donlon S, et al. Photodynamic therapy (PDT) for malignant brain tumors - where do we stand? Photodiagnosis Photodyn Ther 2015;12:530-44.
17. Li X, Lovell JF, Yoon J, Chen X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol 2020;17:657-74.
18. Wang Y, Wang H, Zhou L, et al. Photodynamic therapy of pancreatic cancer: where have we come from and where are we going? Photodiagnosis Photodyn Ther 2020;31:101876.
19. Zhang Z, Li A, Min X, et al. An ROS-sensitive tegafur-PpIX-heterodimer-loaded in situ injectable thermosensitive hydrogel for photodynamic therapy combined with chemotherapy to enhance the tegafur-based treatment of breast cancer. Biomater Sci 2021;9:221-37.
20. Li M, Xu Y, Peng X, Kim JS. From low to No O2-dependent hypoxia photodynamic therapy (hPDT): a new perspective. ACC Chem Res 2022;55:3253-64.
21. Qiu M, Wang D, Huang H, et al. A regioselectively oxidized 2D Bi/BiOx lateral nano-heterostructure for hypoxic photodynamic therapy. Adv Mater 2021;33:e2102562.
22. Duan Z, Luo Q, Dai X, et al. Synergistic therapy of a naturally inspired glycopolymer-based biomimetic nanomedicine harnessing tumor genomic instability. Adv Mater 2021;33:e2104594.
23. Nguyen VN, Yan Y, Zhao J, Yoon J. Heavy-atom-free photosensitizers: from molecular design to applications in the photodynamic therapy of cancer. ACC Chem Res 2021;54:207-20.
24. O’Connor AE, Gallagher WM, Byrne AT. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 2009;85:1053-74.
25. Jin CS, Lovell JF, Chen J, Zheng G. Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly. ACS Nano 2013;7:2541-50.
26. Moan J, Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res 1985;45:1608-10.
27. Li Y, Zhang W, Niu J, Chen Y. Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles. ACS Nano 2012;6:5164-73.
28. Mattila H, Khorobrykh S, Havurinne V, Tyystjärvi E. Reactive oxygen species: reactions and detection from photosynthetic tissues. J Photochem Photobiol B 2015;152:176-214.
29. Li X, Kwon N, Guo T, Liu Z, Yoon J. Innovative strategies for hypoxic-tumor photodynamic therapy. Angew Chem Int Ed 2018;57:11522-31.
30. Sahu A, Kwon I, Tae G. Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia. Biomaterials 2020;228:119578.
31. Sahu A, Choi WI, Tae G. Recent progress in the design of hypoxia-specific nano drug delivery systems for cancer therapy. Adv Ther 2018;1:1800026.
32. LaGory EL, Giaccia AJ. The ever-expanding role of HIF in tumour and stromal biology. Nat Cell Biol 2016;18:356-65.
34. Rodríguez ME, Catrinacio C, Ropolo A, Rivarola VA, Vaccaro MI. A novel HIF-1α/VMP1-autophagic pathway induces resistance to photodynamic therapy in colon cancer cells. Photochem Photobiol Sci 2017;16:1631-42.
35. de Souza AL, Marra K, Gunn J, et al. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer. Br J Cancer 2016;115:805-13.
36. Ding B, Shao S, Yu C, et al. Large-pore mesoporous-silica-coated upconversion nanoparticles as multifunctional immunoadjuvants with ultrahigh photosensitizer and antigen loading efficiency for improved cancer photodynamic immunotherapy. Adv Mater 2018;30:e1802479.
37. Zhang Y, Bo S, Feng T, et al. A versatile theranostic nanoemulsion for architecture-dependent multimodal imaging and dually augmented photodynamic therapy. Adv Mater 2019;31:e1806444.
38. Zhu H, Li Q, Shi B, et al. Dual-emissive platinum(II) metallacage with a sensitive oxygen response for imaging of hypoxia and imaging-guided chemotherapy. Angew Chem Int Ed 2020;59:20208-14.
39. Liu Y, Liu CZ, Wang ZK, et al. Supramolecular organic frameworks improve the safety of clinically used porphyrin photodynamic agents and maintain their antitumor efficacy. Biomaterials 2022;284:121467.
40. Caruso E, Cerbara M, Malacarne MC, Marras E, Monti E, Gariboldi MB. Synthesis and photodynamic activity of novel non-symmetrical diaryl porphyrins against cancer cell lines. J Photochem Photobiol B 2019;195:39-50.
41. Jaque D, Martínez Maestro L, del Rosal B, et al. Nanoparticles for photothermal therapies. Nanoscale 2014;6:9494-530.
42. Chen Q, Xu L, Liang C, Wang C, Peng R, Liu Z. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat Commun 2016;7:13193.
43. Li X, Peng XH, Zheng BD, et al. New application of phthalocyanine molecules: from photodynamic therapy to photothermal therapy by means of structural regulation rather than formation of aggregates. Chem Sci 2018;9:2098-104.
44. Song CW, Rhee JG, Levitt SH. Effect of hyperthermia on hypoxic cell fraction in tumor. Int J Radiat Oncol Biol Phys 1982;8:851-6.
45. Brizel DM, Scully SP, Harrelson JM, et al. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res 1996;56:5347-50.
46. Li W, Wang L, Sun T, et al. Characterization of nanoparticles combining polyamine detection with photodynamic therapy. Commun Biol 2021;4:803.
47. Wang X, Chen M, Zhou J, Zhang X. HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review). Int J Oncol 2014;45:18-30.
48. Sheng D, Liu T, Deng L, et al. Perfluorooctyl bromide & indocyanine green co-loaded nanoliposomes for enhanced multimodal imaging-guided phototherapy. Biomaterials 2018;165:1-13.
49. Lin J, Wang M, Hu H, et al. Multimodal-imaging-guided cancer phototherapy by versatile biomimetic theranostics with UV and γ-irradiation protection. Adv Mater 2016;28:3273-9.
50. Ding M, Shao K, Wu L, et al. A NO/ROS/RNS cascaded-releasing nano-platform for gas/PDT/PTT/immunotherapy of tumors. Biomater Sci 2021;9:5824-40.
51. Li Y, Lu W, Huang Q, Huang M, Li C, Chen W. Copper sulfide nanoparticles for photothermal ablation of tumor cells. Nanomedicine 2010;5:1161-71.
52. Li L, Rashidi LH, Yao M, et al. CuS nanoagents for photodynamic and photothermal therapies: phenomena and possible mechanisms. Photodign Photody Ther 2017;19:5-14.
53. Cheng L, Gong H, Zhu W, et al. PEGylated Prussian blue nanocubes as a theranostic agent for simultaneous cancer imaging and photothermal therapy. Biomaterials 2014;35:9844-52.
54. Cai X, Gao W, Ma M, et al. A prussian blue-based core-shell hollow-structured mesoporous nanoparticle as a smart theranostic agent with ultrahigh pH-responsive longitudinal relaxivity. Adv Mater 2015;27:6382-9.
55. Sahu A, Lee JH, Lee HG, Jeong YY, Tae G. Prussian blue/serum albumin/indocyanine green as a multifunctional nanotheranostic agent for bimodal imaging guided laser mediated combinatorial phototherapy. J Control Release 2016;236:90-9.
56. Sun L, Li Q, Hou M, et al. Light-activatable Chlorin e6 (Ce6)-imbedded erythrocyte membrane vesicles camouflaged Prussian blue nanoparticles for synergistic photothermal and photodynamic therapies of cancer. Biomater Sci 2018;6:2881-95.
57. Yang R, Hou M, Gao Y, et al. Indocyanine green-modified hollow mesoporous Prussian blue nanoparticles loading doxorubicin for fluorescence-guided tri-modal combination therapy of cancer. Nanoscale 2019;11:5717-31.
58. Zhang D, Wu M, Zeng Y, et al. Chlorin e6 conjugated poly(dopamine) nanospheres as PDT/PTT dual-modal therapeutic agents for enhanced cancer therapy. ACS Appl Mater Interfaces 2015;7:8176-87.
59. Feng L, Tao D, Dong Z, et al. Near-infrared light activation of quenched liposomal Ce6 for synergistic cancer phototherapy with effective skin protection. Biomaterials 2017;127:13-24.
60. Zeng W, Zhang H, Deng Y, et al. Dual-response oxygen-generating MnO2 nanoparticles with polydopamine modification for combined photothermal-photodynamic therapy. Chem Eng J 2020;389:124494.
61. Vijayaraghavan P, Liu CH, Vankayala R, Chiang CS, Hwang KC. Designing multi-branched gold nanoechinus for NIR light activated dual modal photodynamic and photothermal therapy in the second biological window. Adv Mater 2014;26:6689-95.
62. Li W, Guo X, Kong F, et al. Overcoming photodynamic resistance and tumor targeting dual-therapy mediated by indocyanine green conjugated gold nanospheres. J Control Release 2017;258:171-81.
63. Yeo ELL, Cheah JU, Lim BY, Thong PSP, Soo KC, Kah JCY. Protein corona around gold nanorods as a drug carrier for multimodal cancer therapy. ACS Biomater Sci Eng 2017;3:1039-50.
64. Yan X, Hu H, Lin J, et al. Optical and photoacoustic dual-modality imaging guided synergistic photodynamic/photothermal therapies. Nanoscale 2015;7:2520-6.
65. Ding YF, Kwong CHT, Li S, et al. Supramolecular nanomedicine derived from cucurbit[7]uril-conjugated nano-graphene oxide for multi-modality cancer therapy. Biomater Sci 2021;9:3804-13.
66. Zhang X, Ong’achwa Machuki J, Pan W, et al. Carbon nitride hollow theranostic nanoregulators executing laser-activatable water splitting for enhanced ultrasound/fluorescence imaging and cooperative phototherapy. ACS Nano 2020;14:4045-60.
67. Lee G, Lee JH, Choi W, Kim C, Hahn SK. Hyaluronate-black phosphorus-upconversion nanoparticle complex for non-invasive theranosis of skin cancer. Biomacromolecules 2022;23:3602-11.
68. Li L, Rashidi LH, Yao M, et al. CuS nanoagents for photodynamic and photothermal therapies: phenomena and possible mechanisms. Photodiagnosis Photodyn Ther 2017;19:5-14.
69. Zhang W, Yu L, Jiang Y, Guo C. Phycocyanin-functionalized black phosphorus quantum dots enhance PDT/PTT therapy by inducing ROS and irreparable DNA damage. Biomater Sci 2021;9:5302-18.
70. Yong Y, Zhou L, Gu Z, et al. WS2 nanosheet as a new photosensitizer carrier for combined photodynamic and photothermal therapy of cancer cells. Nanoscale 2014;6:10394-403.
71. Song L, Chen B, Qin Z, et al. Temperature-dependent CAT-like RGD-BPNS@SMFN nanoplatform for PTT-PDT self-synergetic tumor phototherapy. Adv Healthc Mater 2022;11:e2102298.
72. Feng L, Cheng L, Dong Z, et al. Theranostic liposomes with hypoxia-activated prodrug to effectively destruct hypoxic tumors post-photodynamic therapy. ACS Nano 2017;11:927-37.
73. He H, Du L, Xue H, Wu J, Shuai X. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy. Acta Biomater 2022;149:297-306.
74. Lin LS, Huang T, Song J, et al. Synthesis of copper peroxide nanodots for H2O2 self-supplying chemodynamic therapy. J Am Chem Soc 2019;141:9937-45.
75. Fan JX, Peng MY, Wang H, et al. Engineered bacterial bioreactor for tumor therapy via fenton-like reaction with localized H2O2 generation. Adv Mater 2019;31:e1808278.
76. Hu JJ, Chen Y, Li ZH, Peng SY, Sun Y, Zhang XZ. Augment of oxidative damage with enhanced photodynamic process and MTH1 inhibition for tumor therapy. Nano Lett 2019;19:5568-76.
77. Tang Z, Liu Y, He M, Bu W. Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions. Angew Chem Int Ed 2019;58:946-56.
78. Hwang E, Jung HS. Metal-organic complex-based chemodynamic therapy agents for cancer therapy. Chem Commun 2020;56:8332-41.
79. Lin H, Chen Y, Shi J. Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy. Chem Soc Rev 2018;47:1938-58.
80. Hao YN, Zhang WX, Gao YR, Wei YN, Shu Y, Wang JH. State-of-the-art advances of copper-based nanostructures in the enhancement of chemodynamic therapy. J Mater Chem B 2021;9:250-66.
81. Wang W, Jin Y, Xu Z, et al. Stimuli-activatable nanomedicines for chemodynamic therapy of cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1614.
82. Chudal L, Pandey NK, Phan J, Johnson O, Li X, Chen W. Investigation of PPIX-Lipo-MnO2 to enhance photodynamic therapy by improving tumor hypoxia. Mater Sci Eng C 2019;104:109979.
83. Chudal L, Pandey NK, Phan J, et al. Copper-cysteamine nanoparticles as a heterogeneous fenton-like catalyst for highly selective cancer treatment. ACS Appl Bio Mater 2020;3:1804-14.
84. Liu Y, Zhen W, Jin L, et al. All-in-one theranostic nanoagent with enhanced reactive oxygen species generation and modulating tumor microenvironment ability for effective tumor eradication. ACS Nano 2018;12:4886-93.
85. Kim J, Cho HR, Jeon H, et al. Continuous O2-evolving MnFe2O4 nanoparticle-anchored mesoporous silica nanoparticles for efficient photodynamic therapy in hypoxic cancer. J Am Chem Soc 2017;139:10992-5.
86. Liang H, Guo J, Shi Y, Zhao G, Sun S, Sun X. Porous yolk-shell Fe/Fe3O4 nanoparticles with controlled exposure of highly active Fe0 for cancer therapy. Biomaterials 2021;268:120530.
87. Shen Z, Song J, Yung BC, Zhou Z, Wu A, Chen X. Emerging strategies of cancer therapy based on ferroptosis. Adv Mater 2018;30:e1704007.
88. Shen Z, Liu T, Li Y, et al. Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors. ACS Nano 2018;12:11355-65.
89. Jiang Q, Wang K, Zhang X, et al. Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy. Small 2020;16:e2001704.
90. Yang B, Dai Z, Zhang G, et al. Ultrasmall ternary FePtMn nanocrystals with acidity-triggered dual-ions release and hypoxia relief for multimodal synergistic chemodynamic/photodynamic/photothermal cancer therapy. Adv Healthc Mater 2020;9:e1901634.
91. Yang B, Ding L, Yao H, Chen Y, Shi J. A metal-organic framework (MOF) fenton nanoagent-enabled nanocatalytic cancer therapy in synergy with autophagy inhibition. Adv Mater 2020;32:e1907152.
92. Park E, Chung SW. ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis 2019;10:822.
93. Zhao P, Tang Z, Chen X, et al. Ferrous-cysteine-phosphotungstate nanoagent with neutral pH fenton reaction activity for enhanced cancer chemodynamic therapy. Mater Horiz 2019;6:369-74.
94. Wang X, Wu M, Zhang X, et al. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy. J Nanobiotechnol 2021;19:204.
95. Zhou L, Wu Y, Meng X, et al. Dye-anchored MnO nanoparticles targeting tumor and inducing enhanced phototherapy effect via mitochondria-mediated pathway. Small 2018;14:e1801008.
96. Hou H, Huang X, Wei G, Xu F, Wang Y, Zhou S. Fenton reaction-assisted photodynamic therapy for cancer with multifunctional magnetic nanoparticles. ACS Appl Mater Interfaces 2019;11:29579-92.
97. Feng W, Han X, Wang R, et al. Nanocatalysts-augmented and photothermal-enhanced tumor-specific sequential nanocatalytic therapy in both NIR-I and NIR-II biowindows. Adv Mater 2019;31:e1805919.
98. Bokare AD, Choi W. Review of iron-free Fenton-like systems for activating H2O2 in advanced oxidation processes. J Hazard Mater 2014;275:121-35.
99. Yao M, Ma L, Li L, et al. A new modality for cancer treatment-nanoparticle mediated microwave induced photodynamic therapy. J Biomed Nanotechnol 2016;12:1835-51.
100. Chen J, Fan T, Xie Z, et al. Advances in nanomaterials for photodynamic therapy applications: status and challenges. Biomaterials 2020;237:119827.
101. Nieto-Juarez JI, Pierzchła K, Sienkiewicz A, Kohn T. Inactivation of MS2 coliphage in Fenton and Fenton-like systems: role of transition metals, hydrogen peroxide and sunlight. Environ Sci Technol 2010;44:3351-6.
102. Salazar R, Brillas E, Sirés I. Finding the best Fe2+/Cu2+ combination for the solar photoelectro-fenton treatment of simulated wastewater containing the industrial textile dye disperse blue 3. Appl Catal B Environ 2012;115-6:107-16.
103. Speisky H, Gómez M, Carrasco-Pozo C, Pastene E, Lopez-Alarcón C, Olea-Azar C. Cu(I)-glutathione complex: a potential source of superoxide radicals generation. Bioorg Med Chem 2008;16:6568-74.
104. Li T, Zhou J, Wang L, et al. Photo-fenton-like metal-protein self-assemblies as multifunctional tumor theranostic agent. Adv Healthc Mater 2019;8:e1900192.
105. Liu Y, Wu J, Jin Y, et al. Copper(I) phosphide nanocrystals for in situ self-generation magnetic resonance imaging-guided photothermal-enhanced chemodynamic synergetic therapy resisting deep-seated tumor. Adv Funct Mater 2019;29:1904678.
106. Wan H, Zhang Y, Zhang W, Zou H. Robust two-photon visualized nanocarrier with dual targeting ability for controlled chemo-photodynamic synergistic treatment of cancer. ACS Appl Mater Interfaces 2015;7:9608-18.
107. Wang Z, Ma R, Yan L, Chen X, Zhu G. Combined chemotherapy and photodynamic therapy using a nanohybrid based on layered double hydroxides to conquer cisplatin resistance. Chem Commun 2015;51:11587-90.
108. Su X, Wang WJ, Cao Q, et al. A carbonic anhydrase IX (CAIX)-anchored rhenium(I) photosensitizer evokes pyroptosis for enhanced anti-tumor immunity. Angew Chem Int Ed 2022;61:e202115800.
109. Wang M, Wu M, Liu X, et al. Pyroptosis remodeling tumor microenvironment to enhance pancreatic cancer immunotherapy driven by membrane anchoring photosensitizer. Adv Sci 2022;9:e2202914.
110. Guo W, Li Z, Huang H, et al. VB12-sericin-PBLG-IR780 nanomicelles for programming cell pyroptosis via photothermal (PTT)/photodynamic (PDT) effect-induced mitochondrial DNA (mitoDNA) oxidative damage. ACS Appl Mater Interfaces 2022;14:17008-21.
111. Lu Y, Xu F, Wang Y, et al. Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate. Biomaterials 2021;278:121167.
113. Liu X, Bao X, Hu M, et al. Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer. Nature 2020;588:693-8.
114. Yang B, Gao J, Pei Q, Xu H, Yu H. Engineering prodrug nanomedicine for cancer immunotherapy. Adv Sci 2020;7:2002365.
115. Chen Q, Chen M, Liu Z. Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses. Chem Soc Rev 2019;48:5506-26.
117. Smyth MJ, Ngiow SF, Ribas A, Teng MW. Combination cancer immunotherapies tailored to the tumour microenvironment. Nat Rev Clin Oncol 2016;13:143-58.
118. Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol 2022;23:487-500.
119. Zhang Z, Zhang Y, Xia S, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature 2020;579:415-20.
120. Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol 2017;17:97-111.
121. Xiong H, Ma X, Wang X, et al. Inspired epigenetic modulation synergy with adenosine inhibition elicits pyroptosis and potentiates cancer immunotherapy. Adv Funct Mater 2021;31:2100007.
122. Han X, Cheng K, Xu Y, et al. Modularly designed peptide nanoprodrug augments antitumor immunity of PD-L1 checkpoint blockade by targeting indoleamine 2,3-dioxygenase. J Am Chem Soc 2020;142:2490-6.
123. Cheng K, Ding Y, Zhao Y, et al. Sequentially responsive therapeutic peptide assembling nanoparticles for dual-targeted cancer immunotherapy. Nano Lett 2018;18:3250-8.
124. Zhang Q, Guo X, Cheng Y, et al. Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment. Signal Transduct Target Ther 2020;5:58.
125. Wan D, Yang Y, Liu Y, et al. Sequential depletion of myeloid-derived suppressor cells and tumor cells with a dual-pH-sensitive conjugated micelle system for cancer chemoimmunotherapy. J Control Release 2020;317:43-56.
126. Qiu W, Su W, Xu J, et al. Immunomodulatory-photodynamic nanostimulators for invoking pyroptosis to augment tumor immunotherapy. Adv Healthc Mater 2022;11:e2201233.
127. Zhou F, Wu S, Yuan Y, Chen WR, Xing D. Mitochondria-targeting photoacoustic therapy using single-walled carbon nanotubes. Small 2012;8:1543-50.
128. Chen H, Wan Y, Cui X, Li S, Lee CS. Recent advances in hypoxia-overcoming strategy of aggregation-induced emission photosensitizers for efficient photodynamic therapy. Adv Healthc Mater 2021;10:e2101607.
129. Zhang R, Zeng Q, Li X, Xing D, Zhang T. Versatile gadolinium(III)-phthalocyaninate photoagent for MR/PA imaging-guided parallel photocavitation and photodynamic oxidation at single-laser irradiation. Biomaterials 2021;275:120993.
130. Yang M, Yang T, Mao C. Enhancement of photodynamic cancer therapy by physical and chemical factors. Angew Chem Int Ed 2019;58:14066-80.
131. Zhou H, Liu Z, Zhang Z, et al. Copper-cysteamine nanoparticle-mediated microwave dynamic therapy improves cancer treatment with induction of ferroptosis. Bioact Mater 2023;24:322-30.
132. Wu Q, Xia N, Long D, et al. Dual-functional supernanoparticles with microwave dynamic therapy and microwave thermal therapy. Nano Lett 2019;19:5277-86.
133. Ma L, Chen W, Schatte G, et al. A new Cu-cysteamine complex: structure and optical properties. J Mater Chem C 2014;2:4239-46.
134. Huang X, Wan F, Ma L, et al. Investigation of copper-cysteamine nanoparticles as a new photosensitizer for anti-hepatocellular carcinoma. Cancer Biol Ther 2019;20:812-25.
135. Pandey NK, Chudal L, Phan J, et al. A facile method for the synthesis of copper-cysteamine nanoparticles and study of ROS production for cancer treatment. J Mater Chem B 2019;7:6630-42.
136. Wang P, Wang X, Ma L, et al. Nanosonosensitization by using copper-cysteamine nanoparticles augmented sonodynamic cancer treatment. Part Part Syst Charact 2018;35:1700378.
137. Ma L, Zou X, Chen W. A new X-ray activated nanoparticle photosensitizer for cancer treatment. J Biomed Nanotechnol 2014;10:1501-8.
138. Shrestha S, Wu J, Sah B, et al. X-ray induced photodynamic therapy with copper-cysteamine nanoparticles in mice tumors. Proc Natl Acad Sci USA 2019;116:16823-8.
139. Shi L, Liu P, Wu J, et al. The effectiveness and safety of X-PDT for cutaneous squamous cell carcinoma and melanoma. Nanomedicine 2019;14:2027-43.
140. Chong LM, Tng DJH, Tan LLY, Chua MLK, Zhang Y. Recent advances in radiation therapy and photodynamic therapy. Appl Phys Rev 2021;8:041322.
141. Sah B, Wu J, Vanasse A, et al. Effects of nanoparticle size and radiation energy on copper-cysteamine nanoparticles for X-ray induced photodynamic therapy. Nanomaterials 2020;10:1087.
142. Chen X, Liu J, Li Y, et al. Study of copper-cysteamine based X-ray induced photodynamic therapy and its effects on cancer cell proliferation and migration in a clinical mimic setting. Bioact Mater 2022;7:504-14.
143. Gawande MB, Goswami A, Felpin FX, et al. Cu and Cu-based nanoparticles: synthesis and applications in catalysis. Chem Rev 2016;116:3722-811.
144. Wu T, Liang X, Liu X, et al. Induction of ferroptosis in response to graphene quantum dots through mitochondrial oxidative stress in microglia. Part Fibre Toxicol 2020;17:30.
145. Chu X, Li K, Guo H, et al. Exploration of graphitic-C3N4 quantum dots for microwave-induced photodynamic therapy. ACS Biomater Sci Eng 2017;3:1836-44.
146. Pandey NK, Xiong W, Wang L, et al. Aggregation-induced emission luminogens for highly effective microwave dynamic therapy. Bioact Mater 2022;7:112-25.
147. Chu X, Mao L, Johnson O, et al. Exploration of TiO2 nanoparticle mediated microdynamic therapy on cancer treatment. Nanomedicine 2019;18:272-81.
148. Wang S, Tian R, Zhang X, et al. Beyond photo: xdynamic therapies in fighting cancer. Adv Mater 2021;33:e2007488.
149. Allen C, Her S, Jaffray DA. Radiotherapy for cancer: present and future. Adv Drug Deliv Rev 2017;109:1-2.
150. Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol 2019;25:101084.
151. Chen W, Zhang J. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J Nanosci Nanotechnol 2006;6:1159-66.
152. Chen W. Nanoparticle fluorescence based technology for biological applications. J Nanosci Nanotechnol 2008;8:1019-51.
153. Zou X, Yao M, Ma L, et al. X-ray-induced nanoparticle-based photodynamic therapy of cancer. Nanomedicine 2014;9:2339-51.
154. Liu Z, Xiong L, Ouyang G, et al. Investigation of copper cysteamine nanoparticles as a new type of radiosensitiers for colorectal carcinoma treatment. Sci Rep 2017;7:9290.
155. Liu F, Chen W, Wang SP, Joly AG. Investigation of water-soluble X-ray luminescence nanoparticles for photodynamic activation. Appl Phys Lett 2008;92:43901.
156. Homayoni H, Sahi S, Ma L, et al. X-ray excited luminescence and persistent luminescence of Sr2MgSi2O7:Eu2+, Dy3+ and their associations with synthesis conditions. J Lumin 2018;198:132-7.
157. Ma L, Zou X, Chen W. A new X-ray activated nanoparticle photosensitizer for cancer treatment. J Biomed Nanotechnol 2014;10:1501-8.
158. Chen X, Liu J, Li Y, et al. Study of copper-cysteamine based X-ray induced photodynamic therapy and its effects on cancer cell proliferation and migration in a clinical mimic setting. Bioact Mater 2022;7:504-14.
159. Shrestha S, Wu J, Sah B, et al. X-ray induced photodynamic therapy with copper-cysteamine nanoparticles in mice tumors. Proc Natl Acad Sci USA 2019;116:16823-8.
160. Wang J, Hao L, Li X, Liu S. W18O49@EP nanoparticles improve the anti-tumor effect of radiotherapy and photodynamic therapy by avoiding the limitation of hypoxia. Front Bioeng Biotechnol 2022;10:1060467.
161. Gong L, Zhang Y, Zhao J, et al. All-in-one biomimetic nanoplatform based on hollow polydopamine nanoparticles for synergistically enhanced radiotherapy of colon cancer. Small 2022;18:2205198.
